Closed Loop Medicine appoints Konstantinos Vlassis as Chief Technology Officer

Closed Loop Medicine Ltd. today announced that it has appointed Konstantinos Vlassis as Chief Technology Officer (CTO).

New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient – Biotech Investments

EQS-News: Heidelberg Pharma AG / Key word(s): Study results Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete

October 2, 2024

Operation Warp Speed redux: HHS awards $1.4B to develop next-gen Covid-19 drugs and vaccines

HHS on Tuesday announced it’s pumping $1.4 billion in government funds into next-gen Covid-19 medical products in the pipeline, including $326 million to Regeneron to

August 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Closed Loop Medicine appoints Konstantinos Vlassis as Chief Technology Officer

New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient – Biotech Investments

How can food influence the severity of menopausal hot flashes?

Operation Warp Speed redux: HHS awards $1.4B to develop next-gen Covid-19 drugs and vaccines

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe